Skip to main content

Table 3 Gene expression in chronic kidney disease bone marrow cells not changed after in vitro treatment with pravastatin

From: Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease

 

DMEM ( n = 10)

Pravastatin ( n = 10)

P value

TNFα

1.000 ± 1.290

0.868 ± 0.969

0.7504

eNOS

1.000 ± 4.609

2.161 ± 2.874

0.5422

PKB

1.000 ± 0.889

0.905 ± 0.5512

0.6906

MCP-1

1.000 ± 1.254

1.191 ± 0.6933

0.6101

VEGF

1.000 ± 0.566

0.687 ± 0.464

0.0807

  1. Data presented as mean ± standard deviation, expressed as fold change. DMEM, Dulbecco’s modified Eagle medium; eNOS, endothelial nitric oxide synthase; MCP-1, monocyte chemotactic protein 1; PKB, protein kinase B; TNFα, tumor necrosis factor alpha; VEGF, vascular endothelial growth factor.
Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512